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We present a case of primary oral tuberculosis that led to the diagnosis of HIV infection. Our patient had clinically nonspeciﬁc
ulcersonthelabialmucosaandontheventralsurfaceofthetonguewhichwerediagnosedasbeingtuberculousonlyonhistological
examination. This raised the suspicion of HIV infection that was subsequently conﬁrmed by blood tests. The oral lesions resolved
after 4 weeks of antituberculosis treatment. Some aspects of the pathogenesis of HIV-tuberculosis coinfection are discussed.
1.Introduction
It is estimated that one-third of the world’s population are
infected with Mycobacterium tuberculosis (M.tb). Tubercu-
losis (TB) is a major cause of morbidity and mortality in
developing countries [1]. Only about 11% of the world’s
population live in Africa, but they account for about 30% of
all M.tb-infected subjects in the world [2].
HIV-seropositive subjects are at increased risk of acquir-
ing M.tb infection, of re-activation of latent M.tb infection,
and of more rapid progression of active TB than are HIV-
seronegative subjects. Thus, the epidemic of HIV infection
in Africa is undoubtedly a major factor accounting for the
high prevalence of TB in Africa. In HIV-seropositive subjects
co-infected with M.tb, the TB accelerates the course of HIV
disease [3, 4].
In sub-Saharan Africa, about 80% of subjects with TB
are coinfected with HIV, and it is estimated that in South
Africa 30% of HIV-seropositive subjects have active TB
[4]. M.tb re-activation may occur in the context of only
moderate immunodeﬁciency, but the risk of TB is generally
inversely related to the CD4+T cell count and is greatest
when the CD4+T cell count dips below 200cells/mm3
[3, 4].
Transmission of TB is by inhalation of airborne infec-
tious droplets from persons with active pulmonary TB when
they cough, sneeze, or speak. Extrapulmonary active TB is
not infectious, unless it aﬀects parts of the body such as the
skin or the mouth from which M.tb can be transmitted by
direct contact [5].
M.tb in the oral ﬂuids of people with pulmonary TB is
common, but oral TB is uncommon. This is probably owing
to the protection of the intact oral epithelial barrier against
M.tb penetration, and to the antibacterial properties and the
ﬂushing eﬀects of the saliva [6].
Oral TB usually results from secondary inoculation
of oral mucosa breached by any type of ulceration or
by minor masticatory trauma, by infected sputum, or by
haematogenous dissemination from other infected sites [7,
8]. 0.1%–0.5% of subjects with pulmonary TB will develop
secondary oral TB aﬀecting most commonly the tongue,
followed by the palate, the lips, the buccal mucosa, and the
gingiva [7–10]. It usually manifests as nonhealing ulcers but
may also occur as nodules, granulomata or ﬁssures, or as
tuberculous osteomyelitis of the jaws [7, 8, 11]. Oral TB
ulcersareusuallysingleratherthanmultiple;thetuberculous
ulcer has an indurated, irregular, undermined margin, and a
necrotic base [12].2 Pathology Research International
Figure 1: Ulcer on the ventrum of the tip of the tongue, with
slightly elevated margins and a wide zone of surrounding erythema.
Figure 2: Dorsum of anterior one-third of the tongue with
erythematous, lobulated appearance.
Rarely, oral TB may be brought about by primary infec-
tion by direct inoculation. The site most commonly aﬀected
is the gingiva where primary TB appears as a diﬀuse erythe-
matous patch or as diﬀuse gingival enlargement [10, 11].
Subjects with HIV-M.tb co-infection more frequently
have extrapulmonary TB than do HIV-seronegative subjects,
lymphnodesandcentral-nervoussystembeingthesitesmost
commonly aﬀected [1, 4]. Despite the increasing prevalence
of extrapulmonary TB in HIV-seropositive subjects, the
frequency of oral TB has not increased [1, 4].
We present a case of primary oral TB that led to the
diagnosis of HIV infection.
2. CaseReport of PrimaryTB of
the Oral Mucosa
A 33-year-old black female attended the oral medicine clinic
at the Medunsa Oral Health Centre, University of Limpopo,
complaining of a painful sore on the upper left labial mucosa
of about 3 weeks duration. She appeared to be in good
health. The patient did not smoke or drink alcohol, and she
claimed to be HIV-seronegative as she had been tested for
HIV infection about three months previously.
There were two ulcers surrounded by a wide area of
erythema, one on the upper left labial mucosa that was
painful, and one on the ventral surface of the tip of the
tongue (Figure 1). The margins of both ulcers were slightly
elevated and indurated. The dorsal surface of the anterior
margin of the tongue was hyperaemic with a lobulated
appearance (Figure 2).
Histological examination of the labial mucosal ulcer
showed necrotic tissue and chronically inﬂamed granulation
Figure 3: The chronic granulomatous lesion in the submucosa of
the lip (H&E stain, ×300).
tissue. Scattered epithelioid cells were present, and Ziehl-
Neelsen staining revealed the presence of acid fast bacilli
leading to the ﬁnal diagnosis of oral tuberculosis (Figures 3
and 4).
The patient was referred to the Department of Inter-
nal Medicine at the Dr. George Mukhari Hospital. She
proved to be HIV-seropositive with a CD4+T cell count
of 429cells/mm3. The general physical examination was
unremarkable, the chest radiograph did not show any
evidence of tuberculosis, and other laboratory investigations
that were deemed necessary were all within the range of
normality. A nine-month anti-TB drug regimen of isoniazid,
rifampicin, pyrazinamide, and ethambutol, was prescribed.
The patient did not receive antiretroviral treatment for a
reason to be explained below.
Four weeks after initiation of the anti-TB treatment the
oral lesions were strikingly improved (Figures 5 and 6), and
8 weeks later the previously aﬀected lip and tongue looked
normal.
3. Discussion
M.tb is a slowly-growing, aerobic, nonmotile, noncapsulated
acid-fast bacillus. It is a slowly replicating intracellular
pathogen in macrophages that elicits a T cell immune
response mediated by antigen-speciﬁc CD4+ and CD8+ T
cells. This immune response may eliminate the M.tb, but
more frequently M.tb persists in a latent form, constituting
a reservoir of inactive M.tb that under certain circumstances
may become active. Only 5%–10% of subjects with latent
M.tb infection will develop active TB, but in the remainder
the infection will remain inactive and the infected subjects
will remain asymptomatic for life. Subjects with immuno-
suppressing conditions and children with immature immu-
nity are at higher risk of developing active TB than immuno-
competent subjects. Infection with HIV is the greatest single
risk factor either for the progression of latent infection to
active TB or for acquisition of new M.tb infection [1].
The mechanisms that prevent activation of latent M.tb,
and those that bring active TB infection under control
are poorly characterized [13]. From research done on the
pathogenesis of TB in animals it appears that CD4+T cellsPathology Research International 3
Figure 4: Ziehl-Neelsen stain showing two acid-fast bacilli (arrows,
×1000).
Figure 5 :T h es a m es i t ea ss h o w ni nF i g u r e1,f o u rw e e k sa f t e r
starting antitubercular treatment.
Figure 6: The same region as shown in Figure 2,f o u rw e e k sa f t e r
starting antitubercular treatment.
play an essential role in controlling active M.tb infection,
but only a minor role in preventing re-activation of latent
M.tb infection. On the other hand, CD8+T cells provide
immunity against re-activation of latent infection, but make
onlyalimitedcontributiontothecontainmentofactiveM.tb
infection [13].
In the process of primary M.tb infection, the myco-
bacteria are phagocytosed by macrophages which activate
CD4+T cells. Subsequently both macrophages and CD4+T
cells secrete a variety of cytokines that in turn recruit and
activate lymphocytes and mononuclear phagocytes, which
fuse into multi-nucleated giant cells and generate the typical
T cell mediated immunoinﬂammatory granuloma (tubercle)
that contains the M.tb microorganisms [1, 13]. Reactive
nitric oxide metabolites produced by activated macrophages
play an important role in the intracellular neutralization of
the bacteria [1, 3].
CD8+cytotoxic T eﬀector cells recognize M.tb antigens
on infected macrophages in the context of MHC class
1 molecules and induce either killing of the intracellu-
lar pathogens or lysis of the infected cells by means of
granzymes, granulysin or perforin. Furthermore a Th-1
cytokine proﬁle is important for building up a protective
immunoinﬂammatory response to M.tb infection [1].
HIV-seropositive subjects are at greater risk of activation
of latent M.tb infection, of acquiring new M.tb infection,
including drug-resistant M.tb, and of rapid progression of
active TB disease, than are HIV-seronegative subjects [2,
4]. There is a synergistic relationship between tuberculosis
and HIV infection: each accelerates the progression of the
other; and HIV-seropositive subjects with TB have a shorter
life than TB-free HIV-seropositive subjects with comparable
CD4+T cell counts [2].
The pathogenesis of HIV-M.tb co-infection is complex
and multifactorial. The profound HIV-associated cellular
immune suppression has several identiﬁable characteristics:
a progressive decrease of CD4+T cells, functional impair-
ment of surviving CD4+T cells, functional impairment of
macrophages and polymorphonuclear neutrophils, dysregu-
lation of the cytokine network and CD8+T cell exhaustion.
These factors in concert promote activation of latent M.tb
infection and acquisition of new M.tb from exogenous
sources. In turn, M.tb-speciﬁc chronic activation of the
cellular arm of the immune response adds to the existing
HIV-associated CD4+T-cell and CD8+T-cell exhaustion.
Moreover, M.tb promotes HIV replication by upregulating
CXCR4 surface receptors on alveolar macrophages thus
permitting the more virulent X4 strains of HIV to enter
and replicate in these cells. This leads to further immune
exhaustion and impairment, resulting in the perpetuation of
a pernicious cycle of HIV-M.tb co-infection [2, 14].
If highly active antiretroviral therapy (HAART) is intro-
duced early in the course of HIV disease and if concurrent
TB is treated expeditiously, then this pernicious cycle will
be arrested. It is important to note that the outcome
of treatment of TB in either HIV-seropositive subjects or
HIV-seronegative subjects is similar, but recurrence of, and
mortality rates from TB are greater in HIV-seropositive
subjects [2].
TB may occur at any stage of HIV disease and, as
in the case presented here, may be the ﬁrst indicator
of HIV infection. TB may also sometimes present as an
immunereconstitutioninﬂammatorysyndromeshortlyafter
HAART has brought about a decrease in the HIV load with
consequential signiﬁcant elevation of the CD4+T cell count
[2].
HIV-seropositive subjects and particularly those HIV-
seropositive subjects with low CD4+T cell counts more fre-
quently have extrapulmonary TB than do HIV-seronegative
subjects or HIV-seropositive subjects with high CD4+T
cell counts [2]. Primary extrapulmonary TB is much less
common than secondary extrapulmonary TB, and primary
oral TB as the sole manifestation of TB in an HIV-
seropositive subject, as in our patient, is rare.
The diagnosis of TB in HIV-seropositive subjects is not
always straightforward as the clinical signs and symptoms4 Pathology Research International
of TB in these subjects are not as well deﬁned as in HIV-
seronegative subjects. A comprehensive discussion of the
signs and symptoms of HIV-M.tb co-infection is beyond the
scope of this paper, but it is important to note that HIV-M.tb
co-infected subjects are frequently negative to tuberculin
skin testing, acid fast bacilli are very scant in their sputum
althoughsputumcultureinvariablyconﬁrmspulmonaryTB,
and pulmonary TB granulomas are not always present [2].
The diagnosis of primary oral TB in our patient was
made by biopsy since the clinical features of the oral lesions
were nonspeciﬁc. On microscopical examination, typical
t u b e r c u l o u sg r a n u l o m a sw e r en o te v i d e n t .T h ep r e s e n c eo f
epithelioid cells prompted the Ziehl-Neelsen stain which
revealed the acid-fast bacilli.
Failure to express well-deﬁned granulomas with giant
cells is the result of immune suppression due to HIV co-
infection. Following anti-TB treatment the lesions resolved.
Unfortunately the patient was denied antiretroviral treat-
ment because in government hospitals in South Africa this is
allowed only to patients whose CD4+T cell counts are lower
than 200cells/mm3, but our patient had a CD4+T cell count
of 429cells/mm3. Unfortunately our patient could not aﬀord
the medication privately.
I tw o u l dh a v eb e e na c a d e m i c a l l yi n s t r u c t i v et oh a v e
performed microbiological culture and/or PCR investigation
to determine the speciﬁc type of mycobacterium in our case.
However, in the resource-poor area in which our hospital is
situated in South Africa these tests are not done routinely.
However, since all milk products in the urban area where
the patient lives are pasteurized, and since mycobacterial
speciesotherthanM.tbareuncommonlyencounteredinthis
geographic region, it is reasonable to assume that our patient
was infected with M.tb.
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